Evidence map›Paper›PMID 39035503›Full record

ArticleHeliyon2024

Association of C-reactive protein/albumin ratio with mortality in patients with Traumatic Brain Injury: A systematic review and meta-analysis.

Yuyang Liu, Yaheng Tan, Jun Wan, Qiwen Chen, Yuxin Zheng, Wenhao Xu, Peng Wang, Weelic Chong, Xueying Yu, Yu Zhang

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. C-reactive Protein-to-albumin Ratio (CAR) in Polytrauma-Early Warning or Marker of Disease Evolution?Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuyang LiuCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Yaheng TanPublic Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Jun WanCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Qiwen ChenDepartment of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Yuxin ZhengDepartment of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Wenhao XuCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Peng WangWest China Hospital, Sichuan University, Chengdu, Sichuan, China.
Weelic ChongDepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Xueying YuDepartment of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Yu ZhangCenter for Evidence-based Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study examines the C-reactive protein (CRP)/albumin ratio (CAR) as an inflammation-based prognostic score for predicting mortality in patients with Traumatic Brain Injury (TBI). Methods: We systematically searched the electronic databases PubMed, Embase, and Cochrane up to February 2024. Our inclusion criteria encompassed studies investigating CAR-predicted mortality in patients with TBI. We calculated the Odds Ratio (OR) and associated 95 % confidence intervals (95 % CI) using a random-effects model. Quality assessment of the included studies was appraised using a Newcastle-Ottawa scale. Results: A total of five studies comprising 1040 patients were included in this meta-analysis. The pooled results indicated that CAR was associated with mortality in patients with TBI (OR = 1.88, 95 % CI: 1.05-3.36, P < 0.0001). The findings of subgroup analysis indicated that the relationship between CAR and mortality in patients with TBI did not vary with the severity of the condition. Conclusions: CAR emerges as a valuable prognostic tool for mortality in patients with TBI, underscoring its potential role in early risk stratification and management strategies.

Indexed as

C-Reactive protein/albuminMeta-analysisMortalityRatioTraumatic brain injury

Identifiers

PMID39035503
PMCPMC11259862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.